effective strategies for improving morbidity and mortality outcomes. We tested the hypothesis
that cellular mitochondrial function is a key component of limb pathology and that improving
mitochondrial function represents a novel paradigm for therapy. BALB/c mice were treated
with a therapeutic mitochondrial-targeting peptide (MTP-131) and subjected to limb
ischemia (HLI). Compared to vehicle control, MTP-131 rescued limb muscle capillary density …